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Abstract
Veterans who are discharged from military service due to miscon-
duct are vulnerable to negative health-related outcomes, including
homelessness, incarceration, and suicide. We used national data
from the Veterans Health Administration for 218,608 veterans of
conflicts in Iraq and Afghanistan that took place after the events of
September  11,  2001,  to  compare  clinical  diagnoses  between
routinely-discharged (n = 203,174) and misconduct-discharged (n
= 15,433) veterans. Misconduct-discharged veterans had signific-
antly higher risk for all mental health conditions (adjusted odds ra-
tio [AOR] range, 2.5–8.0) and several behaviorally linked chronic
health conditions (AOR range, 1.2–5.9). Misconduct-discharged
veterans have serious and complex health care needs; prevention
efforts should focus on behavioral risk factors to prevent the de-
velopment and exacerbation of chronic health conditions among
this vulnerable population.
Objective
Approximately 15% of recent US veterans were discharged from
military service for misconduct (1). Compared with routinely-dis-
charged veterans, misconduct-discharged veterans have high risk
for incarceration, homelessness, and suicide (2–4). Studies have
identified mental health disparities among this population (5), but
how misconduct discharge relates to risk for chronic health condi-
tions is unknown. Understanding the prevalence of chronic health
conditions among this vulnerable population is important for un-
derstanding treatment needs and for identifying opportunities to
integrate chronic disease prevention into clinical care. The pur-
pose of this study was to compare comorbidities between miscon-
duct-discharged and routinely-discharged US veterans.
Methods
Data for this study were extracted from national Veterans Health
Administration (VHA) databases and included records from 2006
through 2015 for 218,608 active-duty veterans of conflicts in Iraq
and Afghanistan that took place after the events of September 11,
2001 (9/11). Demographic variables were age, sex, race/ethnicity,
educational status, marital status, branch of service, rank, and type
of discharge. Clinical data included diagnoses assigned by VHA
providers during clinical encounters. Five years of retrospective
follow-up data were included for each veteran, beginning on the
date of each veteran’s initial VHA encounter. Analyses were con-
ducted with R (6) and Stata (7) software through the VA’s secure
VINCI workspace (8). The study was approved by the VA Salt
Lake City Health Care System and the University of Utah institu-
tional review boards.
Discharge type. Interservice Separation Codes, which indicate the
circumstances related to separation from military service, were
classified (5).  Those with a “routine” or  “misconduct-related”
classification were included in this study.
Health status.  The enhanced Elixhauser  comorbidity index al-
gorithm was used to create a set of 31 binary physical and mental
health diagnostic outcomes, indicating the presence or absence of
major chronic health conditions (9). Veterans with one primary
diagnosis or more within a given category were considered to be
positive. Certain outcomes categories (eg, human immunodefi-
ciency virus (HIV), peptic ulcer disease, weight loss), were self-
explanatory. For the rest, the HCUP Clinical Classification Sys-
tem (10) was used to create meaningful subcategories that de-
scribe the types of conditions that comprise each outcome. Subcat-
egories were not exhaustive but provided high coverage of com-
mon conditions.
Data analysis.  We computed descriptive statistics for all  study
variables. Health status variables served as binary outcomes in a
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series of Firth logistic regression models, which were used be-
cause  of  the  low  prevalence  of  certain  conditions  (11).  The
primary predictor variable was discharge type (routine vs miscon-
duct). Covariates were age, sex, education status, marital status,
race/ethnicity, branch of service, and rank. We computed separate
models for men and women. Because of the large number of stat-
istical tests conducted, an α level of .01 was used. We calculated
adjusted odds ratios (AORs) and 99% confidence intervals. We
computed subcategory frequencies for outcomes in which signific-
ant differences were found.
Results
Compared with routinely-discharged veterans, misconduct-dis-
charged veterans had lower levels of education and more were un-
married, served in the Army, and were of enlisted rank (Table 1).
At the beginning of follow up, the average age of the sample was
26.7 years for misconduct-discharged veterans and 31.6 years for
routinely-discharged veterans.
Misconduct discharge was significantly associated with higher risk
for several conditions (Table 2). Among men, misconduct dis-
charge was associated with significantly higher odds for cardiac
arrhythmias (AOR = 1.2), paralysis (AOR = 2.1), neurological dis-
orders (AOR = 2.1), chronic pulmonary disease (AOR = 1.3), liv-
er disease (AOR = 1.6),  peptic ulcer disease (AOR = 1.5),  ac-
quired immunodeficiency syndrome (AIDS)/HIV (AOR = 3.3),
weight loss (AOR = 1.4), and fluid and electrolyte disorders (AOR
= 1.7).
Among women, misconduct discharge was associated with signi-
ficantly  higher  odds  for  neurological  disorders  (AOR =  2.8),
chronic pulmonary disease (AOR = 1.4), liver disease (AOR =
2.5), peptic ulcer disease (AOR = 4.2), metastatic cancer (AOR =
5.9), solid tumor without metastasis (AOR = 2.0), and weight loss
(AOR = 2.1).
Men and women with a misconduct discharge had higher odds for
alcohol abuse, drug abuse, depression, and psychosis (AOR range,
2.5–8.0). For mental health–related outcomes, the presence of dia-
gnoses in multiple subcategories was more common among mis-
conduct-discharged veterans, indicating higher comorbidity (Ta-
ble 3).
Discussion
Misconduct-discharged veterans experience significant disparities
in several chronic health conditions, many of which are behavior-
ally linked, including chronic pulmonary disease, liver disease,
and AIDS/HIV. These disparate risks likely relate to the unique
mental and behavioral health characteristics of this population.
Specifically, misconduct may occur as a result of poor executive
functioning  and decision  making while  in  service,  sometimes
caused by unmet or unrecognized mental health needs. Following
discharge, these factors may continue to drive health and social
outcomes.
Targeted prevention efforts in the VHA may help mitigate the vul-
nerabilities of this population. Integrating chronic disease preven-
tion into the mental health and social services that misconduct-dis-
charged veterans are likely to use may be an effective strategy. In
addition, transitioning the care of misconduct-discharged veterans
from acute settings into integrated primary care settings such as
patient-centered medical homes may enable the VHA to more effi-
ciently meet their complex health needs.
This study has limitations. Diagnostic codes may contain errors,
and codes may be applied inconsistently across providers. Certain
findings, such as high incidence of rare conditions such as cardiac
arrhythmias, merit further study. This sample is based on users of
VHA care, and there may be differences between those who do
and do not access VHA services. We are also unable to assess
non-VHA health service use, and we did not include information
relating to service-connected disability benefit level, which may
factor  into  the  decision to  use  VHA services.  Future  research
should assess symptoms among a broader sample of veterans that
include older cohorts, because disparities may multiply with in-
creasing age.
Results from this study demonstrate that misconduct discharge can
be a marker for behaviorally linked chronic health conditions, and
they underscore the reciprocal relationship between mental and
physical health in both military and civilian settings. Strategies for
improving outcomes among this vulnerable population may in-
clude targeted screening for risky health behaviors and early signs
of chronic health conditions and the integration of preventive care
with mental and behavioral care.
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Tables
Table 1. Demographic and Military Service Characteristics of Active Duty Veterans of Post–9/11 Conflicts in Iraq and Afghanistan (N = 218,608), Veterans Health
Administration, 2006–2015
Characteristic
Womena Mena
Routine (N = 20,835) Misconduct (N = 1,263) Routine (N = 182,339) Misconduct (N = 14,170)
Mean age at first encounter, y (SD) 31.5 (8.4) 26.7 (5.2) 31.6 (8.7) 26.7 (4.6)
Race/ethnicity
White 9,804 (47.1) 569 (45.1) 112,874 (61.9) 8,431 (59.5)
Black 5,938 (28.5) 488 (38.6) 26,287 (14.4) 3,463 (24.4)
Hispanic 2,431 (11.7) 118 (9.3) 20,498 (11.2) 1,490 (10.5)
Other/unknown 2,662 (12.8) 88 (7.0) 22,680 (12.4) 786 (5.5)
Education level
High school/equivalent 15,912 (77.7) 1,127 (90.7) 151,753 (84.6) 13,077 (93.9)
Beyond high school 4,577 (22.3) 116 (9.3) 27,672 (15.4) 846 (6.1)
Marital status
Never married 11,709 (56.4) 856 (68) 100,536 (55.2) 9,685 (68.4)
Married 7,631 (36.7) 356 (28.3) 77,184 (42.4) 4,292 (30.3)
Divorced/other 1,430 (6.9) 46 (3.7) 4,402 (2.4) 177 (1.3)
Branch of service
Army 8,041 (38.6) 720 (57.0) 74,437 (40.8) 8,674 (61.2)
Marines 1,832 (8.8) 44 (3.5) 46,560 (25.5) 1,375 (9.7)
Air Force 5,389 (25.9) 234 (18.5) 26,384 (14.5) 1,345 (9.5)
Navy/Coast Guard 5,573 (26.7) 265 (21.0) 34,956 (19.2) 2,776 (19.6)
Rank
Enlisted 18,994 (91.2) 1,212 (96.0) 169,982 (93.2) 13,874 (97.9)
Officer/Warrant 1,841 (8.8) 51 (4.0) 12,357 (6.8) 296 (2.1)
Abbreviations: 9/11, the events of September 11, 2001; SD, standard deviation.
a Values are no. (%) unless otherwise indicated.
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Table 2. Frequencies and Adjusted Risk for Clinical Comorbidities Over 5 Years of Follow-Up Among Active Duty Veterans of Post–9/11 Conflicts in Iraq and Afgh-
anistan (N = 218,608), Veterans Health Administration, 2006–2015
Elixhauser Category
Women Men
Routine
(N = 20,835)
Misconduct
(N = 1,263)
AORa (99% CI)
Routine
(N = 182,339)
Misconduct
(N = 14,170)
AORa (99% CI)No. (%) No. (%)
Congestive heart failure 34 (0.2) 3 (0.2) 2.13 (0.48–9.54) 324 (0.2) 28 (0.2) 1.44 (0.84–2.47)
Cardiac arrhythmias 464 (2.2) 30 (2.4) 1.03 (0.61–1.72) 4,002 (2.2) 381 (2.7) 1.21 (1.05–1.41)
Valvular disease 76 (0.4) 4 (0.3) 1.20 (0.33–4.30) 460 (0.3) 29 (0.2) 0.97 (0.58–1.62)
Pulmonary circulation disorders 37 (0.2) 4 (0.3) 2.41 (0.62–9.36) 220 (0.1) 23 (0.2) 1.32 (0.72–2.43)
Peripheral vascular disorders 40 (0.2) 2 (0.2) 1.64 (0.29–9.14) 354 (0.2) 28 (0.2) 1.58 (0.93–2.70)
Hypertension, uncomplicated 1,658 (8.0) 86 (6.8) 1.32 (0.97–1.81) 21,623 (11.9) 1,299 (9.2) 1.02 (0.94–1.10)
Hypertension, complicated 15 (0.1) 1 (0.1) 1.97 (0.18–21.00) 200 (0.1) 15 (0.1) 1.30 (0.64–2.67)
Paralysis 24 (0.1) 1 (0.1) 0.95 (0.10–8.90) 269 (0.1) 42 (0.3) 2.05 (1.30–3.24)
Other neurological disorders 212 (1.0) 43 (3.4) 2.84 (1.77–4.57) 1,972 (1.1) 376 (2.7) 2.14 (1.82–2.50)
Chronic pulmonary disease 1,642 (7.9) 143 (11.3) 1.35 (1.05–1.73) 8,993 (4.9) 992 (7) 1.31 (1.20–1.44)
Diabetes, uncomplicated 389 (1.9) 17 (1.3) 1.03 (0.53–2.23) 4,285 (2.4) 196 (1.4) 1.05 (0.86–1.28)
Diabetes, complicated 30 (0.1) 0 (0.0) 0.41 (0.01–17.00) 457 (0.3) 28 (0.2) 1.45 (0.86–2.44)
Hypothyroidism 826 (4.0) 42 (3.3) 1.07 (0.70–1.64) 1,783 (1.0) 104 (0.7) 0.88 (0.67–1.16)
Renal failure 27 (0.1) 1 (0.1) 1.63 (0.17–15.76) 556 (0.3) 43 (0.3) 1.16 (0.74–1.80)
Liver disease 103 (0.5) 12 (10.0) 2.52 (1.10–5.81) 1,519 (0.8) 168 (1.2) 1.58 (1.27–1.98)
Peptic ulcer disease 42 (0.2) 8 (0.6) 4.22 (1.51–11.83) 411 (0.2) 56 (0.4) 1.54 (1.04–2.29)
AIDS/HIV 11 (0.1) 2 (0.2) 3.45 (0.48–25.02) 237 (0.1) 88 (0.6) 3.30 (2.33–4.65)
Lymphoma 19 (0.1) 0 (0.0) 0.79 (0.19–33.61) 171 (0.1) 13 (0.1) 1.17 (0.55–2.50)
Metastatic cancer 15 (0.1) 3 (0.2) 5.87 (1.03–33.84) 114 (0.1) 13 (0.1) 1.56 (0.70–3.47)
Solid tumor without metastasis 231 (1.1) 18 (1.4) 1.96 (1.01–3.84) 1,119 (0.6) 70 (0.5) 1.10 (0.79–1.54)
RA/collagen vascular diseases 292 (1.4) 14 (1.1) 0.98 (0.48–2.00) 1,030 (0.6) 90 (0.6) 1.16 (0.86–1.56)
Coagulopathy 44 (0.2) 5 (0.4) 2.20 (0.85–7.47) 338 (0.2) 26 (0.2) 0.98 (0.57–1.67)
Obesity 1,854 (8.9) 125 (9.9) 1.11 (0.86–1.44) 10,164 (5.6) 686 (4.8) 0.81 (0.73–0.91)
Weight loss 102 (0.5) 15 (1.2) 2.13 (1.02–4.43) 567 (0.3) 82 (0.6) 1.41 (1.02–1.95)
Fluid and electrolyte disorders 170 (0.8) 15 (1.2) 1.57 (0.77–3.20) 862 (0.5) 130 (0.9) 1.74 (1.34–2.25)
Blood loss anemia 31 (0.1) 2 (0.2) 1.35 (0.23–7.89) 26 (0.0) 2 (0.0) 1.15 (0.19–6.90)
Deficiency anemia 383 (1.8) 27 (2.1) 1.21 (0.71–2.05) 403 (0.2) 26 (0.2) 0.86 (0.50–1.48)
Alcohol abuse 604 (2.9) 221 (17.5) 5.58 (4.42–7.07) 13,557 (7.4) 3,558 (25.1) 3.44 (3.25–3.65)
Drug abuse 363 (1.7) 215 (17) 8.04 (6.22–10.40) 7,666 (4.2) 3,339 (23.6) 5.14 (4.82–5.49)
Psychoses 308 (1.5) 63 (5.0) 2.84 (2.40–3.34) 2850 (1.6) 838 (5.9) 2.46 (2.34–2.60)
Depression 8,011 (38.4) 855 (67.7) 2.97 (2.02–4.38) 73,047 (40.1) 9,566 (67.5) 2.95 (2.64–3.30)
Abbreviations: 9/11, the events of September 11, 2001; AIDS, acquired immunodeficiency syndrome; AOR, adjusted odds ratio; CI, confidence interval; HIV, hu-
man immunodeficiency virus; RA, rheumatoid arthritis.
a Odds adjusted for age, race/ethnicity, marital status, education, branch of service, and rank.
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Table 3. Frequencies and Descriptions for Subcategories Composing Selected Categories of Comorbidity Over 5 Years of VHA Follow-Up Among Active Duty Veter-
ans of Post–9/11 Conflicts in Iraq and Afghanistan (N = 218,608), Veterans Health Administration, 2006–2015
Elixhauser Category
Women, %a Men, %a
Routine Misconduct Routine Misconduct
Cardiac arrhythmias
Cardiac dysrhythmias  — 96.5 94.8
Conduction disorders  — 5.8 8.4
Paralysis
Other paralysis  — 85.5 88.1
Hemiplegia  — 14.1 7.1
Other central nervous system disorder  — 5.9 11.9
Other neurological disorders
Convulsions 63.2 79.1 71.1 80.6
Epilepsy 31.1 51.2 31.9 31.4
Hereditary and degenerative nervous system conditions 25.5 4.7 13.1 5.1
Chronic pulmonary disease
Other and unspecific asthma 67.7 53.1 58.7 54.3
Other chronic pulmonary disease 30.9 49.0 32.8 43.5
Chronic airway obstruction; not otherwise specified 8.5 6.3 13.2 9.5
Liver disease
Hepatitis 37.9 66.7 35.9 61.9
Other liver diseases 58.3 25.0 58.7 31.5
Alcohol — related disorders 5.8 8.3 12.7 16.1
Metastatic cancer
Malignancy without site specification 53.3 33.3  —
Secondary malignancy of lymph nodes 26.7 66.7  —
Secondary malignancy of bone 13.3 0  —
Secondary malignancy of brain/spine 6.7 33.3  —
Secondary malignancy of liver 6.7 0  —
Solid tumor without metastasis
Cancer of breast 32.5 22.2  —
Cancer; other primary 29.0 38.9  —
Cancer of uterus and cervix 13.9 16.7  —
Cancer of skin 11.3 5.6  —
Cancer of ovary and other female genital organs 9.1 5.6  —
Cancer of bronchus; lung 2.2 5.6  —
Abbreviation: 9/11, the events of September 11, 2001.
a Percentage of veterans within each Elixhauser comorbidity category who have a diagnosis in the given subcategory. Subcategory tabulations are presented for se-
lected categories where significant differences between discharge types were observed. The most common subcategories were selected for presentation. Totals
may exceed 100% due to co-occurring conditions within the same Elixhauser category.
(continued on next page)
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Table 3. Frequencies and Descriptions for Subcategories Composing Selected Categories of Comorbidity Over 5 Years of VHA Follow-Up Among Active Duty Veter-
ans of Post–9/11 Conflicts in Iraq and Afghanistan (N = 218,608), Veterans Health Administration, 2006–2015
Elixhauser Category
Women, %a Men, %a
Routine Misconduct Routine Misconduct
Fluid and electrolyte disorders
Hypovolemia  — 47.0 59.2
Hypopotassemia  — 30.7 26.9
Hyperpotassemia  — 13.7 6.9
Drug abuse
Drug use disorder, unspecified 71.1 68.8 70.3 71.2
Opioid use disorder 15.7 21.9 24.0 25.4
Cannabis use disorder 30.0 40.9 28.0 37.5
Cocaine use disorder 11.8 26.5 11.5 19.4
Amphetamine use disorder 7.4 8.8 6.0 9.3
Psychosis
Schizophrenia and other psychotic disorders 48.4 66.7 58.0 74.6
Depressive disorders (with psychotic features) 47.7 28.6 36.6 21.6
Bipolar disorders (with psychotic features) 6.8 12.7 6.1 9.7
Depression
Post-traumatic stress disorder 52.1 63.7 73.3 76.0
Depressive disorders (without psychotic features) 69.4 72.0 45.6 55.6
Adjustment disorders 30.1 31.2 29.3 29.3
Abbreviation: 9/11, the events of September 11, 2001.
a Percentage of veterans within each Elixhauser comorbidity category who have a diagnosis in the given subcategory. Subcategory tabulations are presented for se-
lected categories where significant differences between discharge types were observed. The most common subcategories were selected for presentation. Totals
may exceed 100% due to co-occurring conditions within the same Elixhauser category.
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